Alendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis
Treatment with glucocorticoids is associated with bone loss starting soon after therapy is initiated and an increased risk of fracture.We performed a randomized, double-placebo, double-blind clinical trial of 18 months' duration among patients with a rheumatic disease who were starting glucocor...
Shranjeno v:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | angleščina |
| Izdano: |
2006
|
| Online dostop: | https://doi.org/10.1056/nejmoa053569 https://www.nejm.org/doi/pdf/10.1056/NEJMoa053569?articleTools=true |
| Oznake: |
Označite
Brez oznak, prvi označite!
|